{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T06:04:06Z","timestamp":1678169046202},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,5]],"date-time":"2011-09-05T00:00:00Z","timestamp":1315180800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2458-11-687","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T06:21:05Z","timestamp":1315290065000},"source":"Crossref","is-referenced-by-count":3,"title":["An evaluation of factors associated with taking and responding positive to the tuberculin skin test in individuals with HIV\/AIDS"],"prefix":"10.1186","volume":"11","author":[{"given":"L\u00edbia CRV","family":"Moura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo AA","family":"Ximenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helo\u00edsa L","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dem\u00f3crito B","family":"Miranda Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina DP","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosangela MS","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Coimbra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna d'Arc L","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulisses R","family":"Montarroyos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de F\u00e1tima P","family":"Milit\u00e3o Albuquerque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,5]]},"reference":[{"key":"3475_CR1","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1097\/00002030-200111090-00009","volume":"15","author":"JL Johnson","year":"2001","unstructured":"Johnson JL, Okwera A, Hom DL, Mayanja H, Kityo CM, Nsubuga P, Nakibali JG, Loughlin AM, Yun H, Mugyenyi PN, Vernon A, Mugerwa RD, Ellner JJ, Whalen CC: Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. AIDS. 2001, 15: 2137-47. 10.1097\/00002030-200111090-00009.","journal-title":"AIDS"},{"key":"3475_CR2","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","volume":"163","author":"EI Corbett","year":"2003","unstructured":"Corbett EI, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C: The Growing burden of tuberculosis. Arch Intern Med. 2003, 163: 1009-21. 10.1001\/archinte.163.9.1009.","journal-title":"Arch Intern Med"},{"key":"3475_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1258\/0956462053057576","volume":"16","author":"H McShane","year":"2005","unstructured":"McShane H: Co-infection with HIV and TB: double trouble. Intern J of STD & AIDS. 2005, 16: 95-101. 10.1258\/0956462053057576.","journal-title":"Intern J of STD & AIDS"},{"issue":"22","key":"3475_CR4","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1001\/jama.293.22.2719","volume":"293","author":"AD Grant","year":"2005","unstructured":"Grant AD, Charalambous S, Fielding KL, Day JH, Corbett EL, Chaisson RE, De cock KM, Hayes RJ, Churchyard GJ: Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa. A novel randomized incremental recruitment study. JAMA. 2005, 293 (22): 2719-25. 10.1001\/jama.293.22.2719.","journal-title":"JAMA"},{"issue":"1","key":"3475_CR5","first-page":"6","volume":"15","author":"C Lienhardt","year":"2011","unstructured":"Lienhardt C, Cobelens FGJ: Operational research for improved tuberculosis control: the scope, the needs and the way forward. Int J Tuberc Lung Dis. 2011, 15 (1): 6-13.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3475_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1086\/518662","volume":"196","author":"GJ Churchyard","year":"2007","unstructured":"Churchyard GJ, Scano F, Grant AD, Chaisson RE: Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. The J of Infec Dis. 2007, 196: 552-62.","journal-title":"The J of Infec Dis"},{"key":"3475_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1164\/rccm.200606-759OC","volume":"175","author":"R Wood","year":"2007","unstructured":"Wood R, Middelkoop K, Myer L, Grant AD, Whitelaw A, Lawn SD, Kaplan G, Huebner R, Mcintyre J, Belcker LG: Undiagnosed tuberculosis in a community with high HIV prevalence. Implications for tuberculosis control. Am J of Respir and Crit Care Med. 2007, 175: 87-93.","journal-title":"Am J of Respir and Crit Care Med"},{"key":"3475_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAD.0b013e32832ec494","volume":"23","author":"B Grinsztejn","year":"2009","unstructured":"Grinsztejn B, Veloso VG, Friedman RK, Moreira RI, Luz PM, Campos DP, Pilotto JH, Cardoso SW, Keruly JC, Moore RD: Early mortality and cause of deaths in patients using HAART in Brazil and United States. AIDS. 2009, 23: 1-7. 10.1097\/QAD.0b013e3283217f63.","journal-title":"AIDS"},{"issue":"3","key":"3475_CR9","first-page":"567","volume":"50","author":"KH Mayer","year":"2010","unstructured":"Mayer KH, Hamilton CD: Synergistic pandemics: confronting the global HIV and tuberculosis epidemics. CID. 2010, 50 (3): 567-70.","journal-title":"CID"},{"key":"3475_CR10","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1097\/00002030-200009080-00015","volume":"14","author":"E Girardi","year":"2000","unstructured":"Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, Matteelli A, Ippolito G, GISTA: Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS. 2000, 14: 1985-91. 10.1097\/00002030-200009080-00015.","journal-title":"AIDS"},{"key":"3475_CR11","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/00126334-200011010-00002","volume":"25","author":"SM Hsieh","year":"2000","unstructured":"Hsieh SM, Hung CC, Pan SC, Wang JT, Tsai HC, Chen MY, Chang SC: Restoration of cellular immunity against tuberculosis in patients co-infected with HIV-1 and tuberculosis with effective antiretroviral therapy: assessment by determination of CD69 expression on T cells after tuberculin stimulation. J Acquir Immune Defic Syndr. 2000, 25: 212-20. 10.1097\/00126334-200011010-00002.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"14","key":"3475_CR12","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/00002030-200209270-00021","volume":"16","author":"E Girard","year":"2002","unstructured":"Girard E, Palmiere F, Zaccarelli M, Tozzi V, Trotta MP, Selva C, Narciso P, Petrosillo N, Antinori A, Ippolito G: High incidence of tuberculin skin test conversion among HIV-infected individuals who have a favourable immunological response to highly active antiretroviral therapy. AIDS. 2002, 16 (14): 1976-9. 10.1097\/00002030-200209270-00021.","journal-title":"AIDS"},{"key":"3475_CR13","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/01.aids.0000176211.08581.5a","volume":"19","author":"SD Lawn","year":"2005","unstructured":"Lawn SD, Bekker LG, Wood R: How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. AIDS. 2005, 19: 1113-24. 10.1097\/01.aids.0000176211.08581.5a.","journal-title":"AIDS"},{"key":"3475_CR14","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1001\/jama.282.23.2220","volume":"282","author":"B Ledergerber","year":"1999","unstructured":"Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, Battegay M, Vernazza P, Bernasconi E, Opravil M, Kaufmann D, Sudre P, Francioli P, Telenti A: AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV cohort study. JAMA. 1999, 282: 2220-6. 10.1001\/jama.282.23.2220.","journal-title":"JAMA"},{"key":"3475_CR15","first-page":"1026","volume":"4","author":"JL Jones","year":"2000","unstructured":"Jones JL, Hanson DL, Dworkin MS, De Cock KM: HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The adult\/adolescent spectrum of HIV disease group. Int J Tuberc Lung Dis. 2000, 4: 1026-31.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3475_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/00126334-200204010-00010","volume":"29","author":"GJ Dore","year":"2002","unstructured":"Dore GJ, Li Y, McDonald A, Ree H, Kaldo JM: Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Austr\u00e1lia. JAIDS J Acquir Immune Defic Syndr. 2002, 29: 388-95.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"3475_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1086\/338641","volume":"34","author":"G Santoro-Lopes","year":"2002","unstructured":"Santoro-Lopes G, Pinho AMF, Harrison LH, Schechter M: Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. CID. 2002, 34: 543-6. 10.1086\/338641.","journal-title":"CID"},{"key":"3475_CR18","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1126\/science.1086845","volume":"301","author":"BG Williams","year":"2003","unstructured":"Williams BG, Dye C: Antiretroviral drugs for tuberculosis control in the era of HIV\/AIDS. Science. 2003, 301: 1535-7. 10.1126\/science.1086845.","journal-title":"Science"},{"key":"3475_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0025-7753(00)71496-5","volume":"115","author":"EM Alfaro","year":"2000","unstructured":"Alfaro EM, Cuadra F, Solera J, Maci\u00e1 MA, Geijo P, Martinez PAS, Zapata MR, Largo J, Sep\u00falveda MA, Rosa C, S\u00e1nchez L, Espinosa A, Mateos F, Blanch: Evaluaci\u00f3n de dos pautas de quimioprofilaxis tuberculoa em pacientes infectdos por el v\u00edrus de la inmunodefici\u00eancia humana. Medicina Cl\u00ednica. 2000, 115: 161-5.","journal-title":"Medicina Cl\u00ednica"},{"key":"3475_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1086\/324746","volume":"34","author":"JL Casado","year":"2002","unstructured":"Casado JL, Moreno S, Fortin J, Antela A, Quereda C, Navas E, Moreno A, Dronda F: Risk factors for development of Tuberculosis after Isoniazid Chemoprophylaxis in Human Immunodeficiency Virus-Infected Patients. CID. 2002, 34: 386-9. 10.1086\/324746.","journal-title":"CID"},{"key":"3475_CR21","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(97)06532-X","volume":"351","author":"NA Halsey","year":"1998","unstructured":"Halsey NA, Coberly JS, Desoumeaux J, Losikoff P, Atkinson J, Moulton LH, Contave M, Johnson M, Davis H, Geiter L, Johnson E, Huebner R, Boulos R, Chaisson RE: Randomised trai of isosiazid versus rifampicin and pyrazinamide for of tuberculosis in HIV-1 infection. The lancet. 1998, 351: 786-792. 10.1016\/S0140-6736(97)06532-X.","journal-title":"The lancet"},{"key":"3475_CR22","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","volume":"l2","author":"A Mwinga","year":"1998","unstructured":"Mwinga A, Hops M, Godfrey-Faussett P, Quigley M, Mwaba P, Mugala BN, Nyirenda O, Luo N, Pobee J, Elliott AM, McAdam KPWJ, Poeter JDH, et al: Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS. 1998, l2: 2447-2457.","journal-title":"AIDS"},{"key":"3475_CR23","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1097\/00002030-200111090-00008","volume":"15","author":"AMF Pinho","year":"2001","unstructured":"Pinho AMF, Santoro-Lopes G, Harrison LH, Schechter M: Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil. AIDS. 2001, 15: 2129-35. 10.1097\/00002030-200111090-00008.","journal-title":"AIDS"},{"issue":"5","key":"3475_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1157\/13102265","volume":"25","author":"A Rivero","year":"2007","unstructured":"Rivero A, L\u00f3pez-Cort\u00e9s L, Castillo R, Verdejo J, Garcia MA, Martinez-Marcos FJ, Diez F, Escribano JC, Canueto J, Lozano F, Pasquau J, Hernandez JJ, Marquez M, Kindel\u00e1n JM: Grupo Andaluz para el studio de las enfermedades infecciosas. Ensayo cl\u00ednico aleatorizado para evaluar tres pautas cortas de tratamiento de la infecci\u00f3n latente tuberculosa en pacientes infectados por el VIH. Enferm Infecc Microbiol Clin. 2007, 25 (5): 305-10. 10.1157\/13102265.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"6","key":"3475_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0213-005X(03)72942-5","volume":"21","author":"A Rivero","year":"2003","unstructured":"Rivero A, L\u00f3pes-Cortez L, Castillo R, Lozano F, Garcia MA, Diez F, Escribano JC, Canueto J, Pasquau J, Hernandez JJ, Polo R, Mart\u00ednez-Marcos FJ, Kindel\u00e1n JM, Rey R: Grupo Andaluz para el studio de las enfermedades infecciosas. A randomized Trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy. Enferm Infecc Microbiol Clin. 2003, 21 (6): 287-292. 10.1157\/13048575.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"3475_CR26","volume-title":"Interim Policy on collaborative TB\/HIV activities","author":"World Health Organization","year":"2004","unstructured":"World Health Organization: Stop TB department and department of HIV\/AIDS. Interim Policy on collaborative TB\/HIV activities. 2004, Geneva"},{"key":"3475_CR27","volume-title":"Report of a meeting held in Geneva 18-20 February 1998","author":"World Health Organization","year":"1998","unstructured":"World Health Organization, Global tuberculosis programme and UNAIDS: Policy statement on preventive therapy against tuberculosis in people living with HIV. Report of a meeting held in Geneva 18-20 February 1998. 1998, Geneva"},{"key":"3475_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1086\/510080","volume":"44","author":"L Elzi","year":"2007","unstructured":"Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer H, The Swiss HIV Cohort Study: Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. CID. 2007, 44: 94-102. 10.1086\/510080.","journal-title":"CID"},{"key":"3475_CR29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1056\/NEJM199709183371201","volume":"12","author":"CC Whalen","year":"1997","unstructured":"Whalen CC, Johnson JL, Okwera A, Hom DL, Huebner R, Mugyenyi P, Mugerwa RD, Ellner JJ: A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. The New Engl J Med. 1997, 12: 801-8.","journal-title":"The New Engl J Med"},{"key":"3475_CR30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/0140-6736(93)91817-6","volume":"31","author":"JW Pape","year":"1993","unstructured":"Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD: Effect of isoniazida prophylaxis on incidence of active tuberculosis and progression of HIV infection. The Lancet. 1993, 31: 268-72.","journal-title":"The Lancet"},{"key":"3475_CR31","doi-asserted-by":"crossref","unstructured":"Akolo C, Adetifa I, Shepperd S, Volmink J: Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database of Systematic Reviews. 2010, CD000171-1","DOI":"10.1002\/14651858.CD000171.pub3"},{"key":"3475_CR32","first-page":"5221","volume":"161","author":"American Thoracic Society\/Centers for Disease Control and Prevention","year":"2000","unstructured":"American Thoracic Society\/Centers for Disease Control and Prevention: Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000, 161: 5221-47.","journal-title":"Am J Respir Crit Care Med"},{"key":"3475_CR33","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1136\/thorax.55.11.887","volume":"55","author":"British Thoracic Society","year":"2000","unstructured":"British Thoracic Society, Joint tuberculosis committee of British thoracic society: Control and prevention of tuberculosis in United Kingdom: code of practice 2000. THORAX. 2000, 55: 887-901. 10.1136\/thorax.55.11.887.","journal-title":"THORAX"},{"key":"3475_CR34","first-page":"216","volume":"4","author":"TE Tupasi","year":"2000","unstructured":"Tupasi TE, Radhakrishna S, Pascual MLD, Quelapio MI, Villa ML, Co VM, Sarol J, Mangubat N, Reyes AC, Sarmiento A, Solon M, Solon F, Burton L, Lofranco VS, Rostrata MPC, Mantala MJ: BCG coverage and the annual risk of tuberculosis infection over a 14-year period in the Philippines assessed from the nationwide prevalence surveys. Int J Tuberc Lung Dis. 2000, 4: 216-22.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3475_CR35","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1164\/ajrccm.162.4.9911106","volume":"162","author":"LX Zhang","year":"2000","unstructured":"Zhang LX, Tu DH, He GX, Ma ZQ, Nagelkerke NJ, Borgdorff MW, Enarson DA, Broekmans JF: Risk of tuberculosis infection an tuberculous meningitis after discontinuation of Bacillus Calmette-Guerin in Beijing. Am J Respir Crit Care Med. 2000, 162: 1314-7.","journal-title":"Am J Respir Crit Care Med"},{"key":"3475_CR36","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1056\/NEJM199806043382301","volume":"338","author":"A Pablos-Mendes","year":"1998","unstructured":"Pablos-Mendes A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, Cohn DL, Weezenbeek CSB, Kim SJ, Chaulet P, Nunn P: Global surveillance for antituberculosis-drug resistance. N Engl J Med. 1998, 338: 1641-9. 10.1056\/NEJM199806043382301.","journal-title":"N Engl J Med"},{"key":"3475_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAD.0b013e328333acfb","volume":"24","author":"CL Halsema","year":"2010","unstructured":"Halsema CL, Fielding KL, Chihota VN, Russell EC, Lewis JJC, Churchyard GJ, Grant AD: Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting. AIDS. 2010, 24: 1-5. 10.1097\/QAD.0b013e328333acfb.","journal-title":"AIDS"},{"key":"3475_CR38","unstructured":"Smieja MJ, Marchetti CA, Cook DJ, Smaill FM: Isoniazid for preventing tuberculosis in non-HIV infected persons (cochrane review). The cochrane library. 2008, Oxford. Update software, 2"},{"key":"3475_CR39","unstructured":"Woldehanna S, Volmik J: Treatment of latent tuberculosis infection in HIV infected persons (cochrane review). The cochrane library. 2006, Oxford. Update software, 1"},{"key":"3475_CR40","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/aje\/kwq017","volume":"171","author":"PJ Dodd","year":"2010","unstructured":"Dodd PJ, Millington KA, Ghani AC, Mutsvangwa , Butterworth AE, Lalvani A, Corbett EL: Interpreting tuberculin skin tests in a population with a high prevalence of HIV, tuberculosis, and nonspecific tuberculin sensitivity. Am J Epidemiol. 2010, 171: 1037-45. 10.1093\/aje\/kwq017.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"3475_CR41","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1590\/S0034-89102007000800014","volume":"41","author":"FF Jamal","year":"2007","unstructured":"Jamal FF, Moherdaui F: Tuberculose e infec\u00e7\u00e3o pelo HIV no Brasil: magnitude do problema e estrat\u00e9gias para o controle. Rev Sa\u00fade P\u00fablica. 2007, 41 (1): 104-10.","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"3475_CR42","volume-title":"Tuberculose. Guia de vigil\u00e2ncia epidemiol\u00f3gica","author":"Brasil","year":"2009","unstructured":"Brasil, Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia Sanit\u00e1ria: Tuberculose. Guia de vigil\u00e2ncia epidemiol\u00f3gica. 2009, Bras\u00edlia"},{"issue":"10","key":"3475_CR43","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1590\/S1806-37132009001000011","volume":"35","author":"MB Conde","year":"2009","unstructured":"Conde MB, Melo FAF, Marques AMC, Cardoso NC, Pinheiro VGF, Dalcin PTR, et al: III Diretrizes para tuberculose da sociedade brasileira de pneumatologia e tisiologia. J Bras Pneumol. 2009, 35 (10): 1018-48.","journal-title":"J Bras Pneumol"},{"key":"3475_CR44","volume-title":"Recomenda\u00e7\u00f5es para terapia anti-retroviral em adultos infectados pelo HIV","author":"Brasil","year":"2008","unstructured":"Brasil, Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia em Sa\u00fade: Programa Nacional de DST e Aids. Guia de tratamento. Recomenda\u00e7\u00f5es para terapia anti-retroviral em adultos infectados pelo HIV. 2008, Bras\u00edlia"},{"key":"3475_CR45","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","volume":"21","author":"JE Golub","year":"2007","unstructured":"Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, Efron A, Moore RD, Chaisson RE, Durovni B: The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brasil. AIDS. 2007, 21: 1441-48. 10.1097\/QAD.0b013e328216f441.","journal-title":"AIDS"},{"issue":"75","key":"3475_CR46","first-page":"520","volume":"9","author":"F Nuwaha","year":"1998","unstructured":"Nuwaha F: Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-saharan Africa. East African Med J. 1998, 9 (75): 520-7.","journal-title":"East African Med J"},{"key":"3475_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/00002030-199509030-00008","volume":"9","author":"T Aisu","year":"1995","unstructured":"Aisu T, Raviglione MC, van Praag E, Eriki P, Narain JP, Barugahare L, Tembo G, McFarland D, Engwau FA: Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counseling and testing center. AIDS. 1995, 9: 267-73.","journal-title":"AIDS"},{"key":"3475_CR48","volume-title":"Stop TB department and department of HIV\/AIDS","author":"World Health Organization","year":"2011","unstructured":"World Health Organization: Guidelines for intensified tuberculosis case finding and isoniazida preventive therapy for people living with HIV in resource constrained settings. Stop TB department and department of HIV\/AIDS. 2011, Geneva WHO"},{"key":"3475_CR49","unstructured":"Brasil, Minist\u00e9rio da, Sa\u00fade, DATASUS\/MS\/SUS: Tuberculose-Casos confirmados notificados no Sistema de informa\u00e7\u00e3o de Agravos de Notifica\u00e7\u00e3o-SINAN. Accessed march 25, 2010., [ http:\/\/www2.datasus.gov.br\/DATASUS\/index.php?area=01 ]"},{"key":"3475_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2334-9-15","volume":"9","author":"NJ Talati","year":"2009","unstructured":"Talati NJ, Seybold U, Humphrey B, Aina A, Tapia J, Weinfurter P, Albalak R, Blumberg HM: Poor concordance between interferon-\u03b3 release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infectious Diseases. 2009, 9: 15-24. 10.1186\/1471-2334-9-15.","journal-title":"BMC Infectious Diseases"},{"key":"3475_CR51","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/ije\/29.2.369","volume":"29","author":"ML Garcia-Garcia","year":"2000","unstructured":"Garcia-Garcia ML, Valdespino-Gomez JL, Garcia-Sancho C, Mayar-Maya ME, Pal\u00e1cios-Martinez M, Balandrano-Campos S, Escobar-Guiti\u00e9rrez A, Peruga A, Weissenbacher M, Daniels E: Underestimation of Mycobacterium tuberculosis infection in HIV-infected subjects using reactivity to tuberculin and anergy panel. Int J Epidemiol. 2000, 29: 369-75. 10.1093\/ije\/29.2.369.","journal-title":"Int J Epidemiol"},{"key":"3475_CR52","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/01.qai.0000225729.79610.b7","volume":"42","author":"CB Holmes","year":"2006","unstructured":"Holmes CB, Wood R, Badri M, Zilber S, Wang B, Maartens G, Zheng H, Lu Z, Freedberg KA, Losina E: CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr. 2006, 42: 464-9. 10.1097\/01.qai.0000225729.79610.b7.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3475_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00126334-200001010-00010","volume":"23","author":"R Wood","year":"2000","unstructured":"Wood R, Maartens G, Lombard CJ: Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr. 2000, 23: 75-80.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3475_CR54","first-page":"415","volume":"121","author":"C Padmapriyadarsini","year":"2005","unstructured":"Padmapriyadarsini C, Swaminathan S: Preventive therapy for tuberculosis in HIV infected individuals. Indian J Med Res. 2005, 121: 415-23.","journal-title":"Indian J Med Res"},{"key":"3475_CR55","first-page":"789","volume":"169","author":"R Long","year":"2003","unstructured":"Long R, Houston S, Hershfield E: Recommendations for screening and prevention of tuberculosis in patients with HIV and for screening for HIV in patients with tuberculosis and their contacts. CMAJ. 2003, 169: 789-91.","journal-title":"CMAJ"},{"key":"3475_CR56","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1553-2712.1999.tb00161.x","volume":"6","author":"TD Kirsh","year":"1999","unstructured":"Kirsh TD, Chanmugam A, Keyl P, Regan LA, Sharan J, Hexter DA, Kelen GD: Feasibility of an emergency department-based tuberculosis counseling and screening program. Acad Emerg Med. 1999, 6: 224-31. 10.1111\/j.1553-2712.1999.tb00161.x.","journal-title":"Acad Emerg Med"},{"issue":"5","key":"3475_CR57","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/00042560-199604150-00005","volume":"11","author":"RE Chaisson","year":"1996","unstructured":"Chaisson RE, Keruly JC, McAvinue S, Gallant JE, Moore RD: Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1996, 11 (5): 455-9. 10.1097\/00042560-199604150-00005.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-687.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-11-687\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T05:47:44Z","timestamp":1497937664000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-11-687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,5]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["3475"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-11-687","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,5]]},"article-number":"687"}}